Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Hairy Cell

Clinical trial condition

Leukemia, Hairy Cell

Explore clinical trials studying Leukemia, Hairy Cell. Study availability and eligibility vary by location and protocol.

170 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Hairy Cell trial results

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

NCT00132015

Conditions: Angiolymphoid Hyperplasia with Eosinophilia, Blood Coagulation Disorders, Blood Platelet Disorders, +61 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

NCT00064311

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

NCT00003887

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475

Conditions: Anxiety Disorder, Anxiety Disorders, Blast Crisis, +87 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

PS-341 in Treating Patients With Advanced Cancer

NCT00006362

Conditions: Amyloidosis, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Mayo Clinic Rochester, Minnesota, United States

University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00089037

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

NCT00806767

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States

Bergan Mercy Medical Center Omaha, Nebraska, United States

View Trial Details